Filip Bergqvist

467 citations
17 papers · 361 indexed · h-index 10
Topics
Inflammatory mediators and NSAID effects (8 papers)Estrogen and related hormone effects (3 papers)Cancer, Hypoxia, and Metabolism (2 papers)

In The Last Decade

Filip Bergqvist

17 papers receiving 360 citations

Peers

Filip Bergqvist
Comparison fields: 5 of 79
  • Molecular Biology 115
  • Pharmacology 106
  • Oncology 54
  • Neurology 53
  • Neurology 51
Replace Serena Stanga with:
Serena Stanga Italy
Deborah Pietrobono Italy
Candan A Akar United States
Soner Gundemir United States
Maitea Guridi United States
Keya Meyers United States
Xiao‐Liang Liu China
Haiying Chu China
Zhifu Wang China
Filip Bergqvist relative to Serena Stanga Italy Serena Stanga's profile →
Citations per field
00.5×2.7×
Serena Stanga · 1×
Citations per year

Countries citing papers authored by Filip Bergqvist

Since Specialization
Citations

This map shows the geographic impact of Filip Bergqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip Bergqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip Bergqvist more than expected).

Fields of papers citing papers by Filip Bergqvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filip Bergqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip Bergqvist. The network helps show where Filip Bergqvist may publish in the future.

Co-authorship network of co-authors of Filip Bergqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Filip Bergqvist. A scholar is included among the top collaborators of Filip Bergqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filip Bergqvist. Filip Bergqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 3
2 14
3 9
4 7
5 6
6 22
7 21
8 22
9 59
10 21
11
Prostacyclin: a potential novel therapeutic target to treat tendon pain and inflammation
1
12 62
13 6
14 52
15 42
16 12
17 2

About Filip Bergqvist

Filip Bergqvist is a scholar working on Equine, Pharmacology and Neurology, having authored 17 papers that have together received 361 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (8 papers), Estrogen and related hormone effects (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Biological Psychiatry (18 citations), Pharmacology (106 citations) and Neurology (51 citations). Filip Bergqvist has collaborated with scholars based in Sweden, Germany and United Kingdom. Frequent co-authors include Per‐Johan Jakobsson, Ralf Morgenstern, Marina Korotkova, Karin Larsson, Anna Kock, Kristin Jacobsen, Lotta Elfman, Kerstin Iverfeldt, Elena V. Ivanova and John Inge Johnsen. Their work appears in journals such as PLoS ONE, Hepatology and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026